London Stock Exchange Group shareholders will vote on Thursday on whether to potentially double the pay of CEO David ...

American CEOs are confident in the U.S. economy, and they plan on hiring more over the course of the next year. About 87% of CEOs at larger companies say they are confident in the growth prospects ...

PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US Merck’s other top execs received hefty pay increases in 2023. Chief financial officer Caroline ...

This isn’t just about CEOs being greedy. Holding down top pay compresses remuneration lower down, sending ambitious people elsewhere. The UK is struggling with high turnover among chief ...

(Reuters) -Drugmaker AstraZeneca plans to raise its annual dividend by 7% for 2024, it said on Thursday, ahead of a shareholder vote on a hefty boost to its Chief Executive's pay package.

In short: Monopoly power has allowed CEOs of large companies to give themselves large pay rises, University of ... has allowed large companies to hike prices and chief executives to raise their ...

No one likes higher taxes, writes David Olive, but Ottawa has settled on a least-bad way of financing improvements to ...

How much of a difference can 2% make? If you’re talking about body fat, most folks would be thrilled at such a number. But on ...

In recent weeks, a number of CEOs, via their cheerleaders ... in elite circles and is being weaponised in an effort to hike top pay. Hence the claim, made by one of AstraZeneca's biggest ...

An advocacy group representing Canadian doctors is urging the federal government to reconsider the capital gains tax hike.

Three of Canada’s leading regional innovation support agencies won’t join a campaign to press Ottawa to reverse a proposed ...

Drugmaker AstraZeneca AZN-Q plans to raise its annual dividend by 7 per cent for 2024, it said on Thursday, ahead of a shareholder vote on a hefty boost to its Chief Executive’s pay package.